2-chloro-n(6)cyclopentyladenosine has been researched along with Myocardial Infarction in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (40.91) | 18.2507 |
2000's | 12 (54.55) | 29.6817 |
2010's | 1 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duong, HT; Gao, ZG; Jacobson, KA; Joshi, BV; Liang, BT; Sonin, D; Tchilibon, S | 1 |
Anand-Srivastava, MB; Balakumar, P; Reddy, K; Singh, H | 1 |
Forconi, S; Gori, T; Liuni, A; Luca, MC; Münzel, T; Muxel, S; Parker, JD | 1 |
Backx, PH; Batthish, M; Diaz, RJ; Wilson, GJ; Zeng, HP | 1 |
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Lellouche, N; Souktani, R; Tissier, R | 1 |
Gross, GJ; Peart, JN | 1 |
Keith, BJ; Kristo, G; Lasley, RD; Mentzer, RM; Yoshimura, Y | 1 |
Bolli, R; Guo, Y; Li, Q; Stein, AB; Tan, W; Wu, WJ; Zhu, X | 1 |
Baxter, GF; Marber, MS; Patel, VC; Yellon, DM | 1 |
Downey, JM; Olsson, RA; Thompson, R; Tsuchida, A | 1 |
Downey, JM; Liu, Y | 2 |
Downey, JM; Liu, GS; Tsuchida, A; Wilborn, WH | 1 |
Casati, C; Forlani, A; Lozza, G; Monopoli, A | 1 |
Baxter, GF; Yellon, DM | 1 |
Bernardo, NL; Kukreja, RC; Maaieh, MM; Okubo, S; Wood, MA | 1 |
Dana, A; Jonassen, AK; Yamashita, N; Yellon, DM | 1 |
Chelliah, J; Kukreja, RC; Levasseur, JE; Xi, L; Zhao, T | 1 |
Auchampach, JA; Bhattacharya, S; Black, RG; Bolli, R; Kodani, E; Takano, H; Tang, XL; Yang, Z | 1 |
de Zeeuw, S; Duncker, DJ; Liem, DA; van den Doel, MA; Verdouw, PD | 1 |
Latchman, DS; Schulman, D; Yellon, DM | 1 |
Downey, JM; Liu, GS; Olsson, RA; Thornton, JD | 1 |
1 review(s) available for 2-chloro-n(6)cyclopentyladenosine and Myocardial Infarction
Article | Year |
---|---|
Chronic pharmacological preconditioning against ischemia.
Topics: Adenosine; Animals; Cardiotonic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning, Myocardial; Mice; Morphine; Myocardial Infarction; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Swine | 2011 |
21 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Myocardial Infarction
Article | Year |
---|---|
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A3 Receptor Agonists; Animals; Cardiotonic Agents; CHO Cells; Cricetinae; Drug Design; Humans; Mice; Myocardial Infarction; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Reperfusion Injury; Ventricular Function, Left | 2005 |
Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Cardiotonic Agents; Creatine Kinase, MB Form; Female; Glutathione; Heart; Heart Ventricles; Hyperhomocysteinemia; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lactate Dehydrogenases; Male; Methionine; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar; Severity of Illness Index; Thiobarbituric Acid Reactive Substances | 2009 |
Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition.
Topics: Adenosine; Animals; Cells, Cultured; Chloride Channels; Dose-Response Relationship, Drug; Enzyme Activators; Glycolates; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Perfusion; Protein Kinase C; Rabbits; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate | 2002 |
Reperfusion duration paradox with late myocardial preconditioning in rabbits.
Topics: Adenosine; Animals; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Nitric Oxide Donors; Purinergic P1 Receptor Agonists; Rabbits; S-Nitroso-N-Acetylpenicillamine; Time Factors | 2002 |
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors.
Topics: Adenosine; Analgesics, Opioid; Animals; ATP-Binding Cassette Transporters; Benzylidene Compounds; Free Radicals; Heart Diseases; In Vitro Techniques; KATP Channels; Mitochondria, Heart; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Naltrexone; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Opioid, delta; Receptors, Purinergic P1 | 2003 |
Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Heart Ventricles; Hydrogen Peroxide; Ischemic Preconditioning, Myocardial; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocytes, Cardiac; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidants; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Time Factors | 2005 |
Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Amidines; Animals; Benzylamines; Blood Pressure; Body Temperature; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Knockout; Myocardial Infarction; Myocardium; Nitric Oxide Donors; Receptors, Opioid, delta | 2005 |
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Topics: Adenosine; Animals; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Rabbits; Receptors, Purinergic P1; Theophylline; Time Factors | 1994 |
The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
Topics: Acetylcholine; Adenosine; Animals; Bradycardia; Drug Tolerance; Female; Hemodynamics; Hypotension; Infusions, Intravenous; Male; Muscle Proteins; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Purinergic P1 Receptor Antagonists; Rabbits; Receptors, Muscarinic; Receptors, Purinergic P1 | 1994 |
Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein.
Topics: Acetylcholine; Adenosine; Animals; Arrhythmias, Cardiac; GTP-Binding Proteins; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Virulence Factors, Bordetella | 1993 |
Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits.
Topics: Adenosine; Animals; Disease Models, Animal; Female; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Rabbits; Receptors, Purinergic | 1993 |
Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents | 1997 |
Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit.
Topics: Adenosine; Animals; Blood Pressure; Heart Rate; HSP70 Heat-Shock Proteins; Hydrogen-Ion Concentration; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Time Factors | 1997 |
Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K(+) channels in rabbit heart.
Topics: Action Potentials; Adenosine; Adenosine Triphosphate; Animals; Cardiovascular Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Potassium Channels; Rabbits; Time Factors | 1999 |
Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase.
Topics: Adenosine; Animals; Arteries; Coronary Circulation; Coronary Vessels; Hemodynamics; Ischemic Preconditioning, Myocardial; Ligation; Male; Myocardial Infarction; Myocardium; Oligonucleotides, Antisense; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Risk Factors; Superoxide Dismutase; Time Factors | 2000 |
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Topics: Adenosine; Animals; Enzyme Inhibitors; Female; Heart; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Ventricular Function, Left | 2000 |
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
Topics: Adenine; Adenosine; Animals; Binding, Competitive; Cell Line; Consciousness; Decanoic Acids; Humans; Hydroxy Acids; Iodine Radioisotopes; Ischemic Preconditioning, Myocardial; Membranes; Myocardial Infarction; Nitroarginine; Norbornanes; Phenethylamines; Rabbits; Radioligand Assay; Receptor, Adenosine A3; Receptors, Purinergic P1 | 2001 |
Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors.
Topics: Acetamides; Adenosine; Analysis of Variance; Animals; Cryoprotective Agents; Dihydropyridines; Histamine H1 Antagonists; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Pyrilamine; Rats; Rats, Wistar; Receptors, Purinergic; Receptors, Purinergic P1; Theophylline; Time Factors | 2001 |
Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.
Topics: Adenosine; Aging; Animals; Diazoxide; Diglycerides; Heart; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Time Factors; Vasodilator Agents | 2001 |
Ischemic preconditioning protects against infarction in rat heart.
Topics: Adaptation, Physiological; Adenosine; Animals; Coronary Disease; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Infarction; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Ventricular Fibrillation | 1992 |
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
Topics: Adenosine; Animals; Coronary Disease; Female; Heart; Hemodynamics; Injections, Intravenous; Male; Myocardial Infarction; Phenethylamines; Phenylisopropyladenosine; Rabbits | 1992 |